Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content

Prediction of tumor consistency is valuable for planning transsphenoidal surgery for pituitary adenoma. A prospective study was conducted involving 49 participants with pituitary adenoma to determine whether quantitative pharmacokinetic analysis of dynamic contrast-enhanced magnetic resonance imagin...

Full description

Bibliographic Details
Main Authors: Kiyohisa Kamimura, Masanori Nakajo, Manisha Bohara, Daigo Nagano, Yoshihiko Fukukura, Shingo Fujio, Tomoko Takajo, Kazuhiro Tabata, Takashi Iwanaga, Hiroshi Imai, Marcel Dominik Nickel, Takashi Yoshiura
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/15/3914
_version_ 1797525744518168576
author Kiyohisa Kamimura
Masanori Nakajo
Manisha Bohara
Daigo Nagano
Yoshihiko Fukukura
Shingo Fujio
Tomoko Takajo
Kazuhiro Tabata
Takashi Iwanaga
Hiroshi Imai
Marcel Dominik Nickel
Takashi Yoshiura
author_facet Kiyohisa Kamimura
Masanori Nakajo
Manisha Bohara
Daigo Nagano
Yoshihiko Fukukura
Shingo Fujio
Tomoko Takajo
Kazuhiro Tabata
Takashi Iwanaga
Hiroshi Imai
Marcel Dominik Nickel
Takashi Yoshiura
author_sort Kiyohisa Kamimura
collection DOAJ
description Prediction of tumor consistency is valuable for planning transsphenoidal surgery for pituitary adenoma. A prospective study was conducted involving 49 participants with pituitary adenoma to determine whether quantitative pharmacokinetic analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is useful for predicting consistency of adenomas. Pharmacokinetic parameters in the adenomas including volume of extravascular extracellular space (EES) per unit volume of tissue (v<sub>e</sub>), blood plasma volume per unit volume of tissue (v<sub>p</sub>), volume transfer constant between blood plasma and EES (K<sup>trans</sup>), and rate constant between EES and blood plasma (k<sub>ep</sub>) were obtained. The pharmacokinetic parameters and the histologic percentage of collagen content (PCC) were compared between soft and hard adenomas using Mann–Whitney <i>U</i> test. Pearson’s correlation coefficient was used to correlate pharmacokinetic parameters with PCC. Hard adenomas showed significantly higher PCC (44.08 ± 15.14% vs. 6.62 ± 3.47%, <i>p</i> < 0.01), v<sub>e</sub> (0.332 ± 0.124% vs. 0.221 ± 0.104%, <i>p</i> < 0.01), and K<sup>trans</sup> (0.775 ± 0.401/min vs. 0.601 ± 0.612/min, <i>p</i> = 0.02) than soft adenomas. Moreover, a significant positive correlation was found between v<sub>e</sub> and PCC (r = 0.601, <i>p</i> < 0.01). The v<sub>e</sub> derived using DCE-MRI may have predictive value for consistency of pituitary adenoma.
first_indexed 2024-03-10T09:17:20Z
format Article
id doaj.art-d585ff912134416d836ea64ba6b87009
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T09:17:20Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-d585ff912134416d836ea64ba6b870092023-11-22T05:29:57ZengMDPI AGCancers2072-66942021-08-011315391410.3390/cancers13153914Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen ContentKiyohisa Kamimura0Masanori Nakajo1Manisha Bohara2Daigo Nagano3Yoshihiko Fukukura4Shingo Fujio5Tomoko Takajo6Kazuhiro Tabata7Takashi Iwanaga8Hiroshi Imai9Marcel Dominik Nickel10Takashi Yoshiura11Department of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Neurosurgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Pathology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanDepartment of Radiological Technology, Kagoshima University Hospital, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanMR Research & Collaboration, Siemens Healthcare K.K., 1-11-1 Osaki, Shinagawa, Tokyo 141-8644, JapanMR Applications Predevelopment, Siemens Healthcare GmbH, 91052 Erlangen, GermanyDepartment of Radiology, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, JapanPrediction of tumor consistency is valuable for planning transsphenoidal surgery for pituitary adenoma. A prospective study was conducted involving 49 participants with pituitary adenoma to determine whether quantitative pharmacokinetic analysis of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is useful for predicting consistency of adenomas. Pharmacokinetic parameters in the adenomas including volume of extravascular extracellular space (EES) per unit volume of tissue (v<sub>e</sub>), blood plasma volume per unit volume of tissue (v<sub>p</sub>), volume transfer constant between blood plasma and EES (K<sup>trans</sup>), and rate constant between EES and blood plasma (k<sub>ep</sub>) were obtained. The pharmacokinetic parameters and the histologic percentage of collagen content (PCC) were compared between soft and hard adenomas using Mann–Whitney <i>U</i> test. Pearson’s correlation coefficient was used to correlate pharmacokinetic parameters with PCC. Hard adenomas showed significantly higher PCC (44.08 ± 15.14% vs. 6.62 ± 3.47%, <i>p</i> < 0.01), v<sub>e</sub> (0.332 ± 0.124% vs. 0.221 ± 0.104%, <i>p</i> < 0.01), and K<sup>trans</sup> (0.775 ± 0.401/min vs. 0.601 ± 0.612/min, <i>p</i> = 0.02) than soft adenomas. Moreover, a significant positive correlation was found between v<sub>e</sub> and PCC (r = 0.601, <i>p</i> < 0.01). The v<sub>e</sub> derived using DCE-MRI may have predictive value for consistency of pituitary adenoma.https://www.mdpi.com/2072-6694/13/15/3914pituitary adenomaconsistencymagnetic resonance imagingpharmacokinetic analysiscollagen
spellingShingle Kiyohisa Kamimura
Masanori Nakajo
Manisha Bohara
Daigo Nagano
Yoshihiko Fukukura
Shingo Fujio
Tomoko Takajo
Kazuhiro Tabata
Takashi Iwanaga
Hiroshi Imai
Marcel Dominik Nickel
Takashi Yoshiura
Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
Cancers
pituitary adenoma
consistency
magnetic resonance imaging
pharmacokinetic analysis
collagen
title Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
title_full Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
title_fullStr Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
title_full_unstemmed Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
title_short Consistency of Pituitary Adenoma: Prediction by Pharmacokinetic Dynamic Contrast-Enhanced MRI and Comparison with Histologic Collagen Content
title_sort consistency of pituitary adenoma prediction by pharmacokinetic dynamic contrast enhanced mri and comparison with histologic collagen content
topic pituitary adenoma
consistency
magnetic resonance imaging
pharmacokinetic analysis
collagen
url https://www.mdpi.com/2072-6694/13/15/3914
work_keys_str_mv AT kiyohisakamimura consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT masanorinakajo consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT manishabohara consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT daigonagano consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT yoshihikofukukura consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT shingofujio consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT tomokotakajo consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT kazuhirotabata consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT takashiiwanaga consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT hiroshiimai consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT marceldominiknickel consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent
AT takashiyoshiura consistencyofpituitaryadenomapredictionbypharmacokineticdynamiccontrastenhancedmriandcomparisonwithhistologiccollagencontent